Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsRECTALGeneric

NEMBUTAL

PENTOBARBITAL SODIUM

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEMBUTAL is listed in Drugs@FDA under application 083247 (ANDA).

Marketing status: Discontinued Active ingredient PENTOBARBITAL SODIUM Form and strength SUPPOSITORY;RECTAL - 200MG Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 1992-09-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEMBUTAL is listed in Drugs@FDA under application 083247 (ANDA). Marketing status: Discontinued Active ingredient PENTOBARBITAL SODIUM Form and strength SUPPOSITORY;RECTAL - 200MG Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 1992-09-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.